1. Home
  2. ZLAB vs SHO Comparison

ZLAB vs SHO Comparison

Compare ZLAB & SHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

SELL

Current Price

$25.49

Market Cap

2.6B

Sector

Health Care

ML Signal

SELL

Logo Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

SELL

Current Price

$11.35

Market Cap

2.0B

ML Signal

SELL

Company Overview

Basic Information
Metric
ZLAB
SHO
Founded
2013
1995
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
2.0B
IPO Year
2017
2004

Fundamental Metrics

Financial Performance
Metric
ZLAB
SHO
Price
$25.49
$11.35
Analyst Decision
Strong Buy
Buy
Analyst Count
12
12
Target Price
★ $33.14
$11.96
AVG Volume (30 Days)
713.1K
★ 1.6M
Earning Date
11-05-2026
11-06-2026
Dividend Yield
N/A
★ 3.16%
EPS Growth
★ 38.46
N/A
EPS
N/A
★ 0.22
Revenue
$460,156,000.00
★ $1,115,167,000.00
Revenue This Year
N/A
$2.47
Revenue Next Year
$26.50
N/A
P/E Ratio
★ N/A
$51.41
Revenue Growth
★ 15.33
N/A
52 Week Low
$15.96
$8.69
52 Week High
$33.97
$12.07

Technical Indicators

Market Signals
Indicator
ZLAB
SHO
Relative Strength Index (RSI) 51.50 59.24
Support Level $24.81 $10.99
Resistance Level $27.20 $11.46
Average True Range (ATR) 0.87 0.18
MACD -0.10 0.04
Stochastic Oscillator 41.28 82.61

Price Performance

Historical Comparison
ZLAB
SHO

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.

Share on Social Networks: